7521-89-3 Usage
Synonym
L-690330
An alternative name for the compound.
Carboxylic acid group
A functional group (-COOH) present in the molecule that is characteristic of carboxylic acids.
Isoindoline ring system
A heterocyclic aromatic ring structure consisting of a benzene ring fused with a pyridine ring, which is part of the compound's structure.
Diphenylmethylsulfanyl group
A functional group (-S-CH2-C6H5) present in the molecule, consisting of a sulfur atom bonded to a benzyl group, which contributes to the compound's biological activity.
Potent and selective leukotriene D4 receptor antagonist
The compound can specifically block the effects of leukotriene D4, a powerful inflammatory molecule.
Involvement in allergic and inflammatory conditions
Leukotriene D4 is involved in conditions such as asthma and allergic rhinitis, so the compound's antagonistic activity may help treat these conditions.
Subject of research
The compound has been studied for its potential use in treating asthma, allergic rhinitis, and other inflammatory conditions.
Chemical structure and properties
The compound's unique structure and properties make it a promising candidate for further study and potential development as a pharmaceutical drug for the mentioned conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 7521-89-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,5,2 and 1 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 7521-89:
(6*7)+(5*5)+(4*2)+(3*1)+(2*8)+(1*9)=103
103 % 10 = 3
So 7521-89-3 is a valid CAS Registry Number.
7521-89-3Relevant academic research and scientific papers
PHTHALAMIDES, SUCCINIMIDES AND RELATED COMPOUNDS AND THEIR USE AS PHARMACEUTICALS
-
Page/Page column 47, (2008/06/13)
The present invention relates to certain phthalamides, succinimides and related compounds and their use as pharmaceuticals. In particular, the present invention relates to these compounds, pharmaceutical compositions comprising these compounds, and use of these compounds, for example, to inhibit DNA methylation in cells, particularly tumour cells.
